NHS National Cancer Patient Experience Survey
The NHS National Cancer Patient Experience Survey (NCPES) aims to [...]
Promising new immunotherapy combination for advanced kidney cancer
The first results from a phase 2 study (FRACTION-RCC) looking [...]
New treatment for pretreated advanced kidney cancer shows promise
A new treatment, called NDI-101150 has been shown to be [...]
Cancer waiting times – latest updates
Pressure on NHS cancer services has been mounting over the [...]
The Big Cancer52 Conversation
Earlier this week, Sharon Deveson Kell represented kidney cancer patients [...]
How to manage side effects to cabozantinib and nivolumab
This article gives some good advice about how to manage [...]
Government commits to a ‘stand-alone cancer strategy’
Great news yesterday when the Government committed to a 'stand-alone [...]
First CAR T-cell therapy for kidney cancer given Advanced Therapy designation by the FDA
The US Food and Drug Administration (FDA) has granted a [...]
National Kidney Cancer Audit for England and Wales
We are pleased to announce that the first ever National [...]
Belzutifan available on the NHS for patients with VHL disease
We are delighted to announce that the National Institute for [...]
